Retroviruses & CFS/ME: Epigenetics & Mitochondrial Health
Quick Answer
Human Endogenous Retroviruses (HERVs) comprise approximately 8% of human DNA and are normally silenced by epigenetic mechanisms such as DNA methylation. In individuals with treatment-resistant CFS/ME, compromised methylation capacity may allow HERV reactivation, which can trigger NF-kB-mediated immune activation, pro-inflammatory cytokine release, mitochondrial electron transport chain dysfunction, and reduced cerebral blood flow contributing to brain fog and post-exertional malaise.
At a Glance
- Human Endogenous Retroviruses (HERVs) make up approximately 8% of the human genome and are normally kept silent by DNA methylation and histone modifications.
- Loss of epigenetic silencing may allow HERV-derived proteins to activate Toll-like receptors (TLRs) and NF-kB inflammatory pathways, potentially driving chronic immune activation in CFS/ME.
- HERV-driven inflammation has been associated with mitochondrial electron transport chain impairment, reducing ATP production and contributing to post-exertional malaise.
- Neuroimaging research, including work by Biswal et al. (2011) and Nakatomi et al. (2014), has identified reduced cerebral blood flow and neuroinflammation in CFS/ME patients.
- Methylation capacity, MTHFR gene status, and nutrient cofactors (folate, vitamin B12, betaine) are clinically assessable factors that may influence epigenetic regulation of HERVs.
- Functional medicine assessment combining organic acid testing, methylation panels, and inflammatory markers may help identify downstream consequences of HERV dysregulation.
Endogenous Retroviruses: Ancient Viral DNA in Your Genome
Approximately 8% of the human genome is composed of Human Endogenous Retroviruses (HERVs) — remnants of ancient retroviral infections that integrated into the germ line millions of years ago, as documented in the landmark Human Genome Project led by Eric Lander and colleagues [1]. Under normal conditions, these sequences are silenced by epigenetic mechanisms, primarily DNA methylation and histone modifications, which prevent them from being transcribed into active RNA [2].
HERVs are not foreign invaders in the traditional sense. They are part of human DNA, passed from generation to generation. Some HERV-derived sequences have even been co-opted for beneficial functions, such as placental development through syncytin proteins, as identified by Mi et al. in Nature [3]. The problem arises when epigenetic silencing fails.
Why HERVs Matter in CFS/ME
Research has identified increased HERV expression in subsets of patients with autoimmune and neuroinflammatory conditions, including multiple sclerosis, systemic lupus erythematosus, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) [4][5]. Rodrigues et al. (2019) demonstrated elevated HERV-K and HERV-W transcriptional activity specifically in ME/CFS patients. When these sequences become active, they can produce viral-like proteins that trigger innate immune responses — essentially, the immune system begins responding to the body’s own DNA as though it were an active infection.
The Mechanism: When Epigenetic Silencing Fails
Epigenetic control of HERVs depends on several interconnected biochemical systems involving the one-carbon metabolism cycle. DNA methylation — the addition of methyl groups to cytosine bases by DNA methyltransferases (DNMTs) — is the primary mechanism keeping HERVs transcriptionally silent. This process requires adequate methyl donors (folate, vitamin B12, betaine) and functional methylation enzymes, as described by Anderson et al. in the Journal of Nutritional Biochemistry [6].
When methylation capacity is compromised — whether through nutrient deficiency, MTHFR polymorphisms (such as C677T or A1298C variants), chronic psychological stress, or environmental toxicant exposures — HERV sequences may lose their methylation marks and become partially active [7]. This creates a cascade:
| Stage | Mechanism | Key Mediators |
|---|---|---|
| 1. HERV De-repression | Reduced DNA methylation allows transcription of retroviral sequences | DNMTs, methyl donors (folate, B12, betaine) |
| 2. Immune Activation | HERV-derived proteins and RNA trigger pattern recognition receptors | Toll-like receptors (TLR-3, TLR-7), NF-kB, interferon pathways |
| 3. Chronic Inflammation | Sustained immune activation drives pro-inflammatory cytokine production | IL-6, TNF-alpha, IFN-gamma |
| 4. Mitochondrial Stress | Inflammatory cytokines impair mitochondrial electron transport chain function | Complex I-IV dysfunction, reduced ATP output |
This model, supported by the work of Morris and Maes (2014) in Metabolic Brain Disease, helps explain why some CFS/ME patients experience post-exertional malaise — the mitochondria are already operating under inflammatory stress, and additional metabolic demand pushes them past their compromised threshold [9][10].
The Hypoxic Brain: Neuroinflammation and Cerebral Blood Flow
Reduced cerebral blood flow represents one of the most debilitating aspects of CFS/ME, manifesting as cognitive dysfunction commonly described as “brain fog.” Research by Biswal, Kunwar, and Natelson (2011), using arterial spin labeling neuroimaging, identified significantly reduced cerebral blood flow in CFS/ME patients, particularly in the brainstem and prefrontal cortex [11].
The connection to HERV-driven inflammation is significant. Pro-inflammatory cytokines can impair endothelial function and nitric oxide (NO) signalling, reducing vasodilation capacity in cerebral blood vessels. Additionally, neuroinflammation activates microglia — the brain’s resident immune cells — which further disrupts neuronal signalling and energy metabolism, as demonstrated by Nakatomi et al. (2014) using 11C-(R)-PK11195 PET imaging at the RIKEN Center for Life Science Technologies [12].
Clinical Presentation
| Symptom | Proposed Mechanism | Associated Brain Region |
|---|---|---|
| Cognitive impairment (word-finding, concentration, short-term memory) | Microglial activation, reduced neuronal ATP | Prefrontal cortex |
| Orthostatic intolerance | Impaired cerebrovascular autoregulation | Brainstem autonomic centres |
| Post-exertional cognitive crashes | Mitochondrial threshold exceeded under inflammatory stress | Diffuse cortical regions |
| Unrefreshing sleep | Disrupted restorative processes, neuroinflammation | Hypothalamus, brainstem |
Clinical Testing Considerations
Investigating the intersection of epigenetics, immune activation, and mitochondrial function requires a multi-layered functional medicine assessment approach. No single test captures the full picture, but a combination of functional markers can help identify contributing patterns, as outlined by Myhill, Booth, and McLaren-Howard (2009) in the International Journal of Clinical and Experimental Medicine [13].
Recommended Assessment Areas
| Assessment Domain | Recommended Test | What It Reveals |
|---|---|---|
| Methylation status | MTHFR gene testing and Doctors Data methylation panel | Methylation capacity, MTHFR C677T/A1298C variants |
| Organic acids | Organic Acid Test (OAT) by Mosaic Diagnostics | Mitochondrial dysfunction markers, oxidative stress, neurotransmitter metabolism |
| Inflammatory markers | hs-CRP, cytokine panels, immune activation markers | Systemic inflammatory burden, immune activation status |
| Hormonal assessment | DUTCH Complete by Precision Analytical | HPA axis dysregulation, cortisol patterns compounding mitochondrial stress |
The goal is not to diagnose “HERV reactivation” directly — this remains a research-level assessment — but to identify the downstream consequences (impaired methylation, immune activation, mitochondrial stress) that are clinically measurable and therapeutically addressable. Research by de Vega, Vernon, and McGowan (2014) has demonstrated DNA methylation modifications associated with CFS/ME that may serve as future biomarkers [14][15].
Frequently Asked Questions
Key Insights
- Human Endogenous Retroviruses (HERVs) make up approximately 8% of the human genome and are normally silenced by epigenetic mechanisms including DNA methylation.
- Dysregulation of HERV silencing has been linked to chronic inflammation, immune activation, and mitochondrial stress in subsets of CFS/ME patients.
- The overlap between immune activation, mitochondrial dysfunction, and cognitive symptoms (brain fog) may reflect HERV-driven neuroinflammation and reduced cerebral blood flow.
- Methylation capacity, nutrient cofactor status, and environmental exposures are clinically assessable factors that influence epigenetic regulation.
Citable Takeaways
- Approximately 8% of the human genome consists of Human Endogenous Retroviruses (HERVs), as documented in the Human Genome Project by Lander et al. in Nature (2001).
- Rodrigues et al. (2019) identified elevated HERV-K and HERV-W transcriptional activity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients, suggesting a potential link between endogenous retroviral reactivation and immune dysregulation.
- Morris and Maes (2014) proposed that activated immuno-inflammatory, oxidative, and nitrosative stress pathways may impair mitochondrial electron transport chain function in CFS/ME, reducing cellular ATP output.
- Biswal, Kunwar, and Natelson (2011) demonstrated reduced cerebral blood flow in CFS/ME patients using arterial spin labeling, particularly affecting the brainstem and prefrontal cortex.
- Nakatomi et al. (2014) identified widespread neuroinflammation in CFS/ME patients using 11C-(R)-PK11195 PET imaging, providing direct evidence of microglial activation in this condition.
- De Vega, Vernon, and McGowan (2014) found DNA methylation modifications associated with CFS/ME, supporting the epigenetic hypothesis and highlighting potential future diagnostic biomarkers.
Restore Your Energy Balance
If you are living with unexplained or treatment-resistant fatigue, a comprehensive functional medicine assessment at Elemental Health and Nutrition in Adelaide may help clarify contributing factors across methylation, mitochondrial function, and immune activation.
- Consider comprehensive immune and metabolic assessment: A multi-layered testing approach can identify contributing patterns across methylation, mitochondrial function, and immune activation.
- Explore epigenetic factors with a functional medicine practitioner: MTHFR status, methylation capacity, and nutrient cofactors play a central role in maintaining epigenetic silencing of retroviral sequences.
- Develop a personalised recovery protocol: Based on individual test results, targeted support for methylation, mitochondrial function, and inflammation management can be tailored to your specific pattern.
References
- Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860-921.
- Groh S, Schotta G. Silencing of endogenous retroviruses by heterochromatin. Cell Mol Life Sci. 2017;74(11):2055-2065.
- Mi S, Lee X, Li X, et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature. 2000;403(6771):785-9.
- Morandi E, Tanasescu R, Tarlinton RE, et al. The association between human endogenous retroviruses and multiple sclerosis: a systematic review and meta-analysis. PLoS One. 2017;12(2):e0172415.
- Rodrigues LS, da Silva Nali LH, Leal COD, et al. HERV-K and HERV-W transcriptional activity in myalgic encephalomyelitis/chronic fatigue syndrome. Auto Immun Highlights. 2019;10(1):12.
- Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem. 2012;23(8):853-9.
- Friso S, Udali S, De Santis D, Choi SW. One-carbon metabolism and epigenetics. Mol Aspects Med. 2017;54:28-36.
- Hurst TP, Magiorkinis G. Activation of the innate immune response by endogenous retroviruses. J Gen Virol. 2015;96(Pt 6):1207-18.
- Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. 2014;29(1):19-36.
- Tomas C, Brown A, Strassheim V, et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS One. 2017;12(10):e0186802.
- Biswal B, Kunwar P, Natelson BH. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J Neurol Sci. 2011;301(1-2):9-11.
- Nakatomi Y, Mizuno K, Ishii A, et al. Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study. J Nucl Med. 2014;55(6):945-50.
- Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. 2009;2(1):1-16.
- de Vega WC, Vernon SD, McGowan PO. DNA methylation modifications associated with chronic fatigue syndrome. PLoS One. 2014;9(8):e104757.
- Sweetman E, Noble A, Edgar C, et al. Current research provides insight into the biological basis and diagnostic potential for myalgic encephalomyelitis/chronic fatigue syndrome. Diagnostics (Basel). 2019;9(3):73.
